Reinsurance Group of America (NYSE:RGA) Reports Q2 CY2026 In Line With Expectations

Reinsurance Group of America (RGA) reported Q2 CY2026 results. Revenue rose 16.9% year on year to $6.64 billion, matching Wall Street expectations. Non-GAAP profit was $8.89 per share, 37% above analysts’ consensus. Net premiums earned were $4.47 billion, up 7.7% but below consensus. Shares rose 3.7% to $244.93 after the report.

Original reporting
Published Aug 6, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Reinsurance Group of America (NYSE:RGA) Reports Q2 CY2026 In Line With Expectations — source image
Decision brief

The 30-second read

$RGANeutralMed
01

Why it matters

Q2 CY2026 came in with revenue in line and EPS above consensus, but net premiums earned missed, creating a mixed signal for underwriting momentum versus investment-driven support.

02

Market read

The stock’s immediate move (up 3.7%) reflects the EPS beat, while the net premiums earned miss is the main fundamental tension for traders updating estimates.

03

What to watch

The article notes growth deceleration in net premiums earned over two years and highlights investment-income volatility; traders should separate recurring underwriting trends from market-driven float effects.

Relevance 6/10Novelty 6/10Timing: post-results, same-day reaction reported

Background

Reinsurance Group of America is a life and health reinsurer whose results are driven by net premiums earned and investment income on the float.

Company-level read

Ticker impact

$RGANeutralMedium confidence
Context

Reinsurance Group of America reported Q2 CY2026 revenue of $6.64B (+16.9% YoY) and non-GAAP EPS of $8.89, with EPS above consensus but net premiums earned missing.

Expected impact

Near-term bias modestly positive due to EPS beat, but follow-through may be limited by the net premiums earned miss.

Evidence & confidence

The article provides both the upside (EPS beat, stock up 3.7%) and the key offset (net premiums earned missed consensus), which typically drives a two-sided reaction and affects forward estimates.

Market effects

Life reinsurance names may see read-across from premium growth and float/investment income sensitivity, especially if net premiums earned underperformed.

Primarily US-listed insurance sentiment; limited direct regional spillover beyond US insurers/reinsurers.

Reinsurance demand and pricing dynamics can influence global life/health reinsurance risk appetite, but the article is company-specific.

Counterpoint

The net premiums earned miss may be offset by stronger investment income or other line items, so the core business could be healthier than the premium metric alone suggests.

Key entities

  • Reinsurance Group of America

    Life and health reinsurance provider reporting Q2 CY2026 results.

Related articles

$RGAMedAI 8/10

RGA Q2 Earnings Beat Estimates on Higher Premiums, Investment Income

Reinsurance Group of America (RGA) reported Q2 2026 adjusted operating earnings of $8.89 per share, beating the Zacks Consensus by 36.6%. Adjusted operating revenues were $6.7 billion. The company cited higher premiums, investment income, and growth in Financial Solutions, partly offset by higher expenses and foreign currency headwinds. RGA returned $111 million to shareholders and declared a 98-cent dividend.

$RGAMed

REINSURANCE GROUP OF AMERICA INC (RGA): Results of Operations and Financial Condition

REINSURANCE GROUP OF AMERICA INC (RGA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 qfs2q26.htm EX-99.2 Document Exhibit 99.2 Quarterly Financial Supplement Second Quarter 2026 (Unaudited) World Headquarters Internet Address Contacts 16600 Swingley Ridge Road www.rgare.com Laura Cockrill Chesterfield, Missouri 63017 U.S.A. EVP, Chief Financial Officer

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.